Approval based on global Phase 3 program in children demonstrating Dupixent significantly reduced exacerbations (by 54% to 65%) and improved lung function (by 4.68% to 5.32%) compared to placebo ...

Sanofi and Regeneron’s Dupixent approved in Japan for children aged 6 to 11 years with bronchial asthma Approval based on global phase 3 program in children demonstrating Dupixent significantly ...

Approval based on global Phase 3 program in children demonstrating Dupixent significantly reduced exacerbations (by 54% to 65%) and improved lung function (by 4.68% to 5.32%) compared to placebo Dupix ...

Serving as the primary liaison for the $50 billion Rural Health Transformation Program, the ORHT is now responsible for ...

Boehringer Ingelheim has opened another front in its attack on chronic kidney disease (CKD), offering Rectify Pharmaceuticals up to $448 million to partner on a preclinical program.

State auditors flagged mismanagement and political influence in AICS and AKAP, yet the bicameral committee still approved ...

Cybersecurity protection is a C-suite issue that is so fast-changing and technical, it’s hard for CEOs to properly manage.

ESET researchers provide a comprehensive analysis and assessment of a critical severity vulnerability with low likelihood of ...

The program, included in President Donald Trump’s “Big Beautiful Bill,” offers a generous tax incentive to people who donate to scholarship organizations.

From a global regulatory perspective, Cytokinetics is expanding its footprint rapidly. The drug received approval in China on ...

Todd Golden was largely pleased with his team's performance in a 30-point win over Colgate on Sunday. Here's what he said ...

The 2025 Nobel Prize in Physiology or Medicine was awarded to three scientists: Dr. Shimon Sakaguchi (Specially Appointed ...